Vaccine trial | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
May 25, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, MAY 25, 2025

Vaccine trial

A health worker prepares to administer a a vaccine against the Sudan strain of Ebola, during a trial, at Mulago Referral Hospital, in Kampala, Uganda Monday, Feb. 3, 2025. Photo: AP Photo/Hajarah Nalwadda via UNB
Africa

Uganda starts Ebola vaccine trial after outbreak kills nurse

The trial, initiated on Monday, specifically aims at health workers and individuals exposed to the virus

Globe officials assaulted while catching monkeys for vaccine trial
Bangladesh

Globe officials assaulted while catching monkeys for vaccine trial

Syringes are seen in front of a displayed Biontech logo in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

BioNTech expects vaccine trial results for babies by September

Bushra Zafreen Amin. TBS illustration
Thoughts

Ethical considerations of recruiting migrant workers for clinical trials

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
Covid-19 in Bangladesh

India's Bharat Biotech seeks Bangladesh trial for Covid vaccine approved at home

In Brazil, vaccine trial volunteers hope to save lives, not win fame
Coronavirus chronicle

In Brazil, vaccine trial volunteers hope to save lives, not win fame

Coronavirus. Photo: BSS/AFP
Coronavirus chronicle

Second Covid-19 trial paused within 24 hours over safety concerns

Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health minister
Coronavirus chronicle

Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health minister

Photo :Collected
Coronavirus chronicle

Human trials of coronavirus vaccine set to begin in Indonesia

Dr Siddhartha Shankar Joarder
Thoughts

The ethics of vaccine trial on humans

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net